Description

(S)-Octahydropyrazino[2,1-C][1,4]Oxazine CAS NO 1089759-42-1 is a high-purity, advanced pharmaceutical intermediate characterized by its chiral, bicyclic heterocyclic structure. This compound is of significant value in the synthesis of complex active pharmaceutical ingredients (APIs), particularly those targeting central nervous system (CNS) disorders. It is an essential building block for research and development chemists and commercial manufacturers in the global pharmaceutical and fine chemical industries.

Application

• Key Intermediate in API Synthesis: Serves as a critical chiral scaffold in the production of novel therapeutic agents.
• Pharmaceutical Research & Development: Used in medicinal chemistry for the discovery and optimization of new drug candidates, especially for neurological targets.
• Asymmetric Synthesis: Employed in chiral synthesis due to its defined (S)-configuration, enabling the construction of enantiomerically pure compounds.
• Precursor to Biologically Active Molecules: Utilized in the preparation of compounds with potential pharmacological activity.
• Process Chemistry & Scale-Up: Supplied for process development and optimization from laboratory to pilot plant and commercial manufacturing scales.
• Contract Manufacturing: A vital raw material for CDMOs (Contract Development and Manufacturing Organizations) serving the pharmaceutical sector.

Basic Information

Product Name	(S)-Octahydropyrazino[2,1-C][1,4]Oxazine
CAS No.	1089759-42-1
Molecular Formula	C7H14N2O
Molecular Weight	142.20 g/mol
Synonyms	(S)-1,2,3,4,6,7,8,8a-Octahydropyrazino[2,1-c][1,4]oxazine; (S)-Hexahydro-2H-pyrazino[2,1-c][1,4]oxazine; (S)-Octahydro-2H-pyrazino[2,1-c][1,4]oxazine; (S)-Perhydropyrazino[2,1-c][1,4]oxazine; (8aS)-Octahydropyrazino[2,1-c][1,4]oxazine; (S)-Bicyclic Diamine Ether; Chiral Pyrazinooxazine Derivative
EINECS	Contact for details

Quality Control

Our (S)-Octahydropyrazino[2,1-C][1,4]Oxazine is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including chiral purity verification and impurity profiling, to ensure it meets the high standards required for pharmaceutical development. Certificates of Analysis (COA) documenting identity, purity, and chiral excess are available upon request to support your regulatory and quality assurance needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). The product is hygroscopic (moisture-sensitive); keep the container tightly sealed under an inert atmosphere if specified.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Assay (HPLC)	≥98.0%
Chiral Purity (Chiral HPLC)	≥99.0% ee
Water Content (KF)	≤0.5%
Residue on Ignition	≤0.1%
Heavy Metals	≤10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.